202 related articles for article (PubMed ID: 15235064)
21. [Metaiodobenzylguanidine scintigraphy in the diagnosis and followup of neuroblastoma. Apropos of 16 cases].
Hammami H; Hassine L; Mhiri A; Sellem A; Oubich F; Gharssallah L; Barsaoui S; Ben Brahim H
Tunis Med; 2007 May; 85(5):413-6. PubMed ID: 17657930
[TBL] [Abstract][Full Text] [Related]
22. A comparison of targeting of neuroblastoma with mIBG and anti L1-CAM antibody mAb chCE7: therapeutic efficacy in a neuroblastoma xenograft model and imaging of neuroblastoma patients.
Hoefnagel CA; Rutgers M; Buitenhuis CK; Smets LA; de Kraker J; Meli M; Carrel F; Amstutz H; Schubiger PA; Novak-Hofer I
Eur J Nucl Med; 2001 Mar; 28(3):359-68. PubMed ID: 11315605
[TBL] [Abstract][Full Text] [Related]
23. Localized infant neuroblastomas often show spontaneous regression: results of the prospective trials NB95-S and NB97.
Hero B; Simon T; Spitz R; Ernestus K; Gnekow AK; Scheel-Walter HG; Schwabe D; Schilling FH; Benz-Bohm G; Berthold F
J Clin Oncol; 2008 Mar; 26(9):1504-10. PubMed ID: 18349403
[TBL] [Abstract][Full Text] [Related]
24. Management of Neuroblastoma: ICMR Consensus Document.
Bansal D; Totadri S; Chinnaswamy G; Agarwala S; Vora T; Arora B; Prasad M; Kapoor G; Radhakrishnan V; Laskar S; Kaur T; Rath GK; Bakhshi S
Indian J Pediatr; 2017 Jun; 84(6):446-455. PubMed ID: 28367616
[TBL] [Abstract][Full Text] [Related]
25. [Recent advances on retroperitoneal neuroblastoma].
De Grazia E; Cimador M; De Bernardi B
Arch Ital Urol Androl; 1997 Sep; 69(4):233-40. PubMed ID: 9417295
[TBL] [Abstract][Full Text] [Related]
26. Updates in Diagnosis, Management, and Treatment of Neuroblastoma.
Swift CC; Eklund MJ; Kraveka JM; Alazraki AL
Radiographics; 2018; 38(2):566-580. PubMed ID: 29528815
[TBL] [Abstract][Full Text] [Related]
27. Functional-metabolic imaging of neuroblastoma.
Sharp SE; Parisi MT; Gelfand MJ; Yanik GA; Shulkin BL
Q J Nucl Med Mol Imaging; 2013 Mar; 57(1):6-20. PubMed ID: 23474631
[TBL] [Abstract][Full Text] [Related]
28. MIBG and somatostatin receptor analogs in children: current concepts on diagnostic and therapeutic use.
Pashankar FD; O'Dorisio MS; Menda Y
J Nucl Med; 2005 Jan; 46 Suppl 1():55S-61S. PubMed ID: 15653652
[TBL] [Abstract][Full Text] [Related]
29. Phase II study on the effect of disease sites, age, and prior therapy on response to iodine-131-metaiodobenzylguanidine therapy in refractory neuroblastoma.
Matthay KK; Yanik G; Messina J; Quach A; Huberty J; Cheng SC; Veatch J; Goldsby R; Brophy P; Kersun LS; Hawkins RA; Maris JM
J Clin Oncol; 2007 Mar; 25(9):1054-60. PubMed ID: 17369569
[TBL] [Abstract][Full Text] [Related]
30. Neuroblastoma.
Shah S; Ravindranath Y
Indian J Pediatr; 1998; 65(5):691-705. PubMed ID: 10773924
[TBL] [Abstract][Full Text] [Related]
31. Neuroblastoma: an enigmatic disease.
Brossard J; Bernstein ML; Lemieux B
Br Med Bull; 1996 Oct; 52(4):787-801. PubMed ID: 9039732
[TBL] [Abstract][Full Text] [Related]
32. [Neuroblastoma. Current clinical and therapeutic aspects. Contributions of modern biology].
Hartmann O; Favrot MC
Rev Prat; 1993 Nov; 43(17):2182-6. PubMed ID: 8146533
[TBL] [Abstract][Full Text] [Related]
33. Quantitative study of radioiodinated metaiodobenzylguanidine uptake in children with neuroblastoma: correlation with tumor histopathology.
Moyes JS; Babich JW; Carter R; Meller ST; Agrawal M; McElwain TJ
J Nucl Med; 1989 Apr; 30(4):474-80. PubMed ID: 2738676
[TBL] [Abstract][Full Text] [Related]
34. Initial diagnosis and treatment follow up of neuroblastoma invasion of inferior vena cava with I-123 metaiodobenzylguanidine scintigraphy.
Huang S; Yang H; Zhuang H
Clin Nucl Med; 2006 Nov; 31(11):718-20. PubMed ID: 17053395
[TBL] [Abstract][Full Text] [Related]
35. The role of 131 iodine-metaiodobenzylguanidine scanning in the correlative imaging of patients with neuroblastoma.
Andrich MP; Shalaby-Rana E; Movassaghi N; Majd M
Pediatrics; 1996 Feb; 97(2):246-50. PubMed ID: 8584386
[TBL] [Abstract][Full Text] [Related]
36. [Follow-up evaluation of metastatic neuroblastoma using high dose [131I-meta]iodobenzylguanidine].
Klingebiel T; Reuland P; Feine U; Niethammer D
Nuklearmedizin; 1992 Dec; 31(6):209-12. PubMed ID: 1491958
[TBL] [Abstract][Full Text] [Related]
37. [Scintigraphy with radioiodinated meta-iodobenzylguanidine in the diagnosis of neuroblastoma].
Müller-Gärtner HW; Erttmann R; Helmke K
Nuklearmedizin; 1985 Dec; 24(5-6):222-6. PubMed ID: 3912731
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of stage 4 neuroblastoma patients by means of MIBG and 99mTc-MDP scintigraphy.
Turba E; Fagioli G; Mancini AF; Rosito P; Galli A; Alvisi P
J Nucl Biol Med (1991); 1993 Sep; 37(3):107-14. PubMed ID: 8218456
[TBL] [Abstract][Full Text] [Related]
39. Neuroblastoma arising from the organ of Zuckerkandl: an unusual site with a favorable biologic outcome.
Berdon WE; Stylianos S; Ruzal-Shapiro C; Hoffer F; Cohen M
Pediatr Radiol; 1999 Jul; 29(7):497-502. PubMed ID: 10398782
[TBL] [Abstract][Full Text] [Related]
40. Diagnosis and treatment of neuroblastoma using 131I-meta-iodobenzylguanidine.
Edeling CJ; Büchler Frederiksen P; Kamper J; Jeppesen P
Nuklearmedizin; 1986 Oct; 25(5):172-5. PubMed ID: 3797256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
